Medical device company R3 Vascular Inc., a developer of novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), has announced the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs.
News | Cardiovascular Business
R3 Vascular Appoints Josh Smale as Vice President of Global Clinical and Scientific Affairs

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM).
News | ACC
Study Calls for Targeted Strategies for Managing Diabetic Cardiomyopathy Across Racial, Ethnic Groups

July 10, 2024 — Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal ...

Home July 10, 2024
Home
the cardiology clinic of the future
Feature | Remote Monitoring | By Stuart Long
Step Into the Cardiology Clinic of the Future: Bringing Virtual Cardiac Care Delivery and Virtual Telemetry to Life in Your Practice’s Clinical Workflows

In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovascular ...

Home July 10, 2024
Home
ProtheraCytes
News | Cardiovascular Clinical Studies
CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes for the Treatment of Acute Myocardial Infarction

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH in patients with chronic obstructive pulmonary disease (COPD) or sickle cell disease (SCD)
News | Pharmaceuticals
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...

Home July 10, 2024
Home
Keith Churchwell, M.D., FAHA, has been named new volunteer president at the American Heart Association for fiscal year 2024-2025.
News | AHA
American Heart Association Announces New 2024-2025 National Volunteer Leaders

July 9, 2024 — The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading ...

Home July 09, 2024
Home
Counties tend to be more rural and socioeconomically disadvantaged
News | Cardiovascular Business
Almost Half of US Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY Endovascular Robotic Surgical System
News | Cardiovascular Clinical Studies
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
Vivek Reddy, MD
News | Atrial Fibrillation
Pulsed Field Ablation Procedures Found Safe and Effective for Atrial Fibrillation Patients

July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF) ...

Home July 08, 2024
Home
Optum webinar pic
News | Structural Heart
Webinar on Optimizing Structural Heart Workflows to Take Place Next Week

On July 16, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows ...

Home July 08, 2024
Home
During the American Heart Association Basic Cardiovascular Sciences (BCVS) Scientific Sessions 2024 taking place in Chicago this week, two new, basic research studies in rodents (mice and rats) analyzed the impacts that alcohol may have on the heart.
News | AHA
New Research on Alcohol’s Impact on the Heart at American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024

July 24, 2024 — During the American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024, BCVS ...

Home July 05, 2024
Home
Happy 4th from the DAIC team in Chicago
Feature | Cardiovascular Business
Happy 4th from the DAIC team

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
Researchers call for monitoring of quality, outcomes in era of private equity ownership
News | Cardiovascular Business
Study: Private Equity Acquisitions in Cardiology on the Rise

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Jon Kobashigawa, MD, of the Smidt Heart Institute at Cedars-Sinai, is an expert in heart transplantation, heart failure, and other complex cardiac conditions
News | Structural Heart
Cedars-Sinai Cardiologist Leads the American Society of Transplantation

July 3, 2024 — Jon Kobashigawa, MD, director of the Heart Transplant Program in the Department of Cardiology in the ...

Home July 03, 2024
Home
Globally approved maximum diameter expansion aims to provide new options in larger diameter and tapered vessels
News | Stents Drug Eluting
Biotronik Introduces Expanded Maximum Diameter Dimensions for Orsiro Mission DES

July 2, 2024 — Biotronik announced the availability of an expanded Maximum Allowed Diameters (MAD) range for the Orsiro ...

Home July 02, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now